Navigation Links
Roche Diagnostics Named to FORTUNE magazine's 2013 list of "100 Best Companies to Work For"
Date:1/17/2013

INDIANAPOLIS, Jan. 17, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche Diagnostics Corporation has been selected to FORTUNE magazine's annual list of the "100 Best Companies to Work For." Roche debuted at 89 on the list and is the only Indiana-based company selected.

(Photo:  http://photos.prnewswire.com/prnh/20130117/DE44332 )

"Being named a 'Best Company to Work For' validates what we already know about our organization," said Jack Phillips , president and CEO of Roche Diagnostics. "Roche is not only a leader in personalized healthcare; we're also a leader in attracting and developing the best people. We are successful only because our people are successful and I couldn't be prouder that our entire workforce is being recognized by this award."

In selecting Roche Diagnostics for the list, Fortune magazine cited the company's on-site medical clinic and fitness center; $30,000 budget for intramural sports; and health insurance plans tiered to income levels.

The entire list of the 2013 "100 Best Companies to Work For" is available at www.fortune.com/bestcompanies.

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011
'/>"/>

SOURCE Roche Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
3. Roche announces FDA approval of HIV viral load test
4. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
5. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
6. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
7. Rochester Medical Reports Third Quarter Results
8. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
9. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
10. Roche cytomegalovirus viral load test now available in US
11. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... August 28, 2015 According to ... Tumor (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) ... Discovery, Prognostic) & Geography - Global Forecast to 2020", ... to reach around 17,689.0 Million USD by 2020 at ... 2015 to 2020. Browse 191 Tables ...
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/686gwf/investigation ) ... on China,s Bevacizumab Market ,2010-2019" report to their ... name of Avastin, bevacizumab injection is the first angiogenesis ... approved by CFDA to treat metastatic colorectal cancer. Currently, ... all come from Roche and its subsidiary Genectech. In ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Bevacizumab Market 2015-2019 2
... July 12 Ferring Pharmaceuticals Inc., the makers of ... Bat for the Cure charity, in an effort to "strike-out ... the organization,s Minor League Baseball initiative across the country. FIRMAGON® is ... , , ...
... (B. Braun) announced today the availability of large volume heparin infusion solutions. , ... (Logo:   http://photos.prnewswire.com/prnh/20081022/NYW008LOGO ) , ...   http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ) , , , ... States Pharmacopeia (USP) standards for heparin products released by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 2Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 3Ferring Pharmaceuticals' FIRMAGON® Named Official Sponsor of Ed Randall's Bat for the Cure 4B. Braun Large Volume Heparin Infusion Solutions Now Available 2B. Braun Large Volume Heparin Infusion Solutions Now Available 3
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Month 2015 in September by sharing the facts about the role of heredity ... and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions to have both ...
(Date:8/31/2015)... ... August 31, 2015 , ... In preparation for this November’s National Family Caregivers ... personal sound amplifier, is offering caregivers “7 Reasons to Care about Hearing Health.” The ... with a variety of home healthcare challenges, specifically as they relate to caring for ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... airway management device that could effectively deliver oxygen with a lower risk of ... a better way, I invented the Adam Device." , The Adam Device offers ...
(Date:8/31/2015)... ... ... For 12 years, since 2004, the Mesothelioma Applied Research Foundation ... . On this day, and in the weeks leading up to it, the Meso ... cause. , “One of the ways a person can be involved is by wearing ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... A year ... the team is preparing to release a new issue commemorating the successful first year. ... information they need for a potentially difficult time in their lives,” says Melissa Wolfert, ...
Breaking Medicine News(10 mins):Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3
... reduce infant mortality in the U.S., according to a study ... A 10 percent increase in hospital use of basic ... births, the study found. A complete national transition to electronic ... the U.S. Many health professionals have advocated electronic records ...
... May 18, 2011 The American Society for Gastrointestinal ... of its program specifically dedicated to promoting quality in ... the United States. The ASGE Endoscopy Unit Recognition Program ... privileging, quality assurance, endoscopy reprocessing and CDC infection control ...
... 18 (HealthDay News) -- A flame retardant banned years ago in ... is among a number of potentially toxic flame retardants found in ... chairs, a new study reports. Flame retardants are used to ... number of products -- catching fire, and to slow the rate ...
... , WEDNESDAY, May 18 (HealthDay News) -- Deprivation and ... new study suggests. Researchers examined DNA samples collected ... Romania taking part in a long-term study. Some of ... transferred to high-quality foster care at different ages. ...
... you run a mile? If you,re middle-aged, the answer could ... stroke over the next decade or more. In two separate ... a middle-age person can run a mile can help predict the ... men and could be an early indicator of cardiovascular disease for ...
... care in the United States says that the rapidly growing ... ill patients raises serious concerns about whose interests are being ... those of dying patients and their loved ones. "Under ... of interest between a company,s drive to maximize profits and ...
Cached Medicine News:Health News:Electronic medical records lower infant mortality, study finds 2Health News:ASGE recognizes 30 endoscopy units for quality and safety 2Health News:ASGE recognizes 30 endoscopy units for quality and safety 3Health News:Potentially Toxic Flame Retardants Found in Baby Products 2Health News:Early Adversity May Shorten Child's Life 2Health News:Simple fitness test could predict long-term risk for heart attack, stroke in middle-aged people 2Health News:Simple fitness test could predict long-term risk for heart attack, stroke in middle-aged people 3Health News:Rise of for-profit hospice industry raises troubling questions, new study says 2